112 related articles for article (PubMed ID: 8531592)
1. Short-term cardiovascular effects of somatostatin in patients with cirrhosis.
Gaudin C; Moreau R; Champigneulle B; Soubrane O; Kleber G; Lebrec D
Liver; 1995 Oct; 15(5):236-41. PubMed ID: 8531592
[TBL] [Abstract][Full Text] [Related]
2. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
Jenkins SA; Nott DM; Baxter JN
HPB Surg; 1998; 11(1):13-21. PubMed ID: 9830576
[TBL] [Abstract][Full Text] [Related]
4. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
[TBL] [Abstract][Full Text] [Related]
5. Immediate effects of different schedules of somatostatin on portal pressure in patients with liver cirrhosis.
Zhang C; Xu JM; Kong DR; Min XK; Chen R
J Clin Pharm Ther; 2013 Jun; 38(3):206-11. PubMed ID: 23437909
[TBL] [Abstract][Full Text] [Related]
6. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.
Villanueva C; Planella M; Aracil C; López-Balaguer JM; González B; Miñana J; Balanzó J
Am J Gastroenterol; 2005 Mar; 100(3):624-30. PubMed ID: 15743361
[TBL] [Abstract][Full Text] [Related]
8. The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis.
Nevens F; Sprengers D; Fevery J
J Hepatol; 1994 Jan; 20(1):27-31. PubMed ID: 7911136
[TBL] [Abstract][Full Text] [Related]
9. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat.
Jenkins SA; Devitt P; Day DW; Baxter JN; Shields R
Digestion; 1986; 33(3):126-34. PubMed ID: 2868955
[TBL] [Abstract][Full Text] [Related]
10. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion.
Sieber CC; Beglinger C; Bart S; Tschoepl M; Currie G; Larsen F; Drewe J
Clin Pharmacol Ther; 2004 Jan; 75(1):70-9. PubMed ID: 14749693
[TBL] [Abstract][Full Text] [Related]
11. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
McCormick PA; Chin J; Greenslade L; Karatapanis S; Dick R; McIntyre N; Burroughs AK
Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
14. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
[TBL] [Abstract][Full Text] [Related]
15. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.
Escorsell A; Bandi JC; Andreu V; Moitinho E; García-Pagán JC; Bosch J; Rodés J
Gastroenterology; 2001 Jan; 120(1):161-9. PubMed ID: 11208725
[TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis.
Eriksson LS; Brundin T; Söderlund C; Wahren J
Scand J Gastroenterol; 1987 Oct; 22(8):919-25. PubMed ID: 2891184
[TBL] [Abstract][Full Text] [Related]
18. Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease.
Matrella E; Valatas V; Notas G; Roumpaki H; Xidakis C; Hadzidakis A; Mouzas I; Kouroumalis E
Aliment Pharmacol Ther; 2001 Jun; 15(6):857-64. PubMed ID: 11380324
[TBL] [Abstract][Full Text] [Related]
19. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat.
Jenkins SA; Baxter JN; Corbett WA; Shields R
Br J Surg; 1985 Nov; 72(11):864-7. PubMed ID: 2866012
[TBL] [Abstract][Full Text] [Related]
20. Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
Kalambokis G; Tsiouris S; Tsianos EV; Baltayiannis G; Pakou B; Fotopoulos A
Liver Int; 2010 Oct; 30(9):1371-8. PubMed ID: 20738780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
